These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 26551044)

  • 41. A randomized, multinational, noninferiority, phase III trial to evaluate the safety and efficacy of BF-200 aminolaevulinic acid gel vs. methyl aminolaevulinate cream in the treatment of nonaggressive basal cell carcinoma with photodynamic therapy.
    Morton CA; Dominicus R; Radny P; Dirschka T; Hauschild A; Reinhold U; Aschoff R; Ulrich M; Keohane S; Ekanayake-Bohlig S; Ibbotson S; Ostendorf R; Berking C; Gröne D; Schulze HJ; Ockenfels HM; Jasnoch V; Kurzen H; Sebastian M; Stege H; Staubach P; Gupta G; Hübinger F; Ziabreva I; Schmitz B; Gertzmann A; Lübbert H; Szeimies RM
    Br J Dermatol; 2018 Aug; 179(2):309-319. PubMed ID: 29432644
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Photodynamic therapy using topical 5-aminolaevulinic acid vs. surgery for basal cell carcinoma.
    Cosgarea R; Susan M; Crisan M; Senila S
    J Eur Acad Dermatol Venereol; 2013 Aug; 27(8):980-4. PubMed ID: 22738399
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fractionated aminolevulinic acid-photodynamic therapy provides additional evidence for the use of PDT for non-melanoma skin cancer.
    de Haas ER; de Vijlder HC; Sterenborg HJ; Neumann HA; Robinson DJ
    J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):426-30. PubMed ID: 18031503
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reflectance confocal microscopy allows in vivo real-time noninvasive assessment of the outcome of methyl aminolaevulinate photodynamic therapy of basal cell carcinoma.
    Venturini M; Sala R; Gonzàlez S; Calzavara-Pinton PG
    Br J Dermatol; 2013 Jan; 168(1):99-105. PubMed ID: 23013443
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Methyl aminolevulinate photodynamic therapy after partial debulking in the treatment of superficial and nodular basal cell carcinoma: 3-years follow-up.
    Gómez C; Cobos P; Alberdi E
    Photodiagnosis Photodyn Ther; 2021 Mar; 33():102176. PubMed ID: 33429099
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Urticaria after methyl aminolevulinate photodynamic therapy in a patient with nevoid basal cell carcinoma syndrome.
    Wolfe CM; Green WH; Hatfield HK; Cognetta AB
    J Drugs Dermatol; 2012 Nov; 11(11):1364-5. PubMed ID: 23135091
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Giant and large basal cell carcinoma treated with topical photodynamic therapy.
    Eibenschutz L; Marenda S; Buccini P; De Simone P; Ferrari A; Mariani G; Silipo V; Catricalà C
    Eur J Dermatol; 2008; 18(6):663-6. PubMed ID: 18955200
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Photodynamic therapy in the management of basal cell carcinoma: Retrospective evaluation of outcome.
    Jerjes W; Hamdoon Z; Hopper C
    Photodiagnosis Photodyn Ther; 2017 Sep; 19():22-27. PubMed ID: 28442314
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Topical methyl aminolevulinate.
    Siddiqui MA; Perry CM; Scott LJ
    Am J Clin Dermatol; 2004; 5(2):127-37; discussion 138-40. PubMed ID: 15109276
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The relationship between protoporphyrin IX photobleaching during real-time dermatological methyl-aminolevulinate photodynamic therapy (MAL-PDT) and subsequent clinical outcome.
    Tyrrell JS; Campbell SM; Curnow A
    Lasers Surg Med; 2010 Sep; 42(7):613-9. PubMed ID: 20806386
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term follow-up of topical 5-aminolaevulinic acid photodynamic therapy diode laser single session for non-melanoma skin cancer.
    Souza CS; Felicio LB; Ferreira J; Kurachi C; Bentley MV; Tedesco AC; Bagnato VS
    Photodiagnosis Photodyn Ther; 2009; 6(3-4):207-13. PubMed ID: 19932453
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Photodynamic therapy for basal cell carcinomas in organ-transplant recipients.
    Guleng GE; Helsing P
    Clin Exp Dermatol; 2012 Jun; 37(4):367-9. PubMed ID: 22420420
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Topical methyl aminolaevulinate photodynamic therapy versus cryotherapy for superficial basal cell carcinoma: a 5 year randomized trial.
    Basset-Seguin N; Ibbotson SH; Emtestam L; Tarstedt M; Morton C; Maroti M; Calzavara-Pinton P; Varma S; Roelandts R; Wolf P
    Eur J Dermatol; 2008; 18(5):547-53. PubMed ID: 18693158
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Photodynamic therapy for basal cell carcinoma: clinical and pathological determinants of response.
    Fantini F; Greco A; Del Giovane C; Cesinaro AM; Venturini M; Zane C; Surrenti T; Peris K; Calzavara-Pinton PG
    J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):896-901. PubMed ID: 21054566
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combination ALA-PDT and ablative fractional Er:YAG laser (2,940 nm) on the treatment of severe acne.
    Yin R; Lin L; Xiao Y; Hao F; Hamblin MR
    Lasers Surg Med; 2014 Mar; 46(3):165-72. PubMed ID: 24391075
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of superficial basal cell carcinoma with photodynamic therapy. Observational study in 22 patients with 5-aminolaevulinic acid and methyl aminolaevulinate.
    Alique-García S; Company-Quiroga J; Sánchez Campos A; Hernández Núñez A; Borbujo J
    Photodiagnosis Photodyn Ther; 2019 Jun; 26():190-192. PubMed ID: 30914392
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Consensus recommendations for the treatment of basal cell carcinomas in Gorlin syndrome with topical methylaminolaevulinate-photodynamic therapy.
    Basset-Seguin N; Bissonnette R; Girard C; Haedersdal M; Lear JT; Paul C; Piaserico S
    J Eur Acad Dermatol Venereol; 2014 May; 28(5):626-32. PubMed ID: 23581795
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hexyl aminolevulinate, 5-aminolevulinic acid nanoemulsion and methyl aminolevulinate in photodynamic therapy of non-aggressive basal cell carcinomas: A non-sponsored, randomized, prospective and double-blinded trial.
    Salmivuori M; Grönroos M; Tani T; Pölönen I; Räsänen J; Annala L; Snellman E; Neittaanmäki N
    J Eur Acad Dermatol Venereol; 2020 Dec; 34(12):2781-2788. PubMed ID: 32196772
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Photodynamic therapy and imiquimod immunotherapy for basal cell carcinomas.
    Nikkels AF; Piérard-Franchimont C; Nikkels-Tassoudji N; Bourguignon R; Piérard GE
    Acta Clin Belg; 2005; 60(5):227-34. PubMed ID: 16398319
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Methyl aminolevulinate photodynamic therapy for onychomycosis: a multicentre, randomized, controlled clinical trial.
    Gilaberte Y; Robres MP; Frías MP; García-Doval I; Rezusta A; Aspiroz C
    J Eur Acad Dermatol Venereol; 2017 Feb; 31(2):347-354. PubMed ID: 27515478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.